← Back to Search

Electrical Stimulation

Electrical Stimulation for Osteoarthritis

N/A
Waitlist Available
Research Sponsored by Cionic, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 weeks, 12 weeks
Awards & highlights

Summary

This trial will look at how electrical stimulation through a home-based medical device can help people with knee osteoarthritis (KOA) by improving muscle mass, strength, walking, pain, & perceived function.

Who is the study for?
Adults aged 22-75 with knee osteoarthritis who can walk for 30 minutes and tolerate an electrical stimulation device for up to an hour. They should not have had a change in medication or symptom exacerbation recently, no injections into the knees in the past year, and no history of severe arthritis, neurological diseases, or use of similar devices.Check my eligibility
What is being tested?
The trial is testing if a home-based program using electrical stimulation over 12 weeks improves muscle strength, pain relief, walking ability, and overall function in adults with knee osteoarthritis compared to those without such stimulation.See study design
What are the potential side effects?
Potential side effects may include discomfort from the device's electrical stimulation leading to skin irritation or muscle fatigue. There might also be temporary increased joint pain after exercise sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 weeks, 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 weeks, 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Maximal Voluntary Isometric Contraction of the Quadriceps Using a Dynamometer
Change in Perceived Pain Scores Assessed by the Western Ontario/McMaster Universities Osteoarthritis Index (WOMAC)
Other outcome measures
Adherence to the Program
Change in Functional Ability of the Lower Limb
Change in Perceived Functional Capacity
+3 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: NMES and FESExperimental Treatment3 Interventions
Device: Cionic Neural Sleeve NS-100. Participants will wear the device during the 12-week exercise and walking program and receive stimulation assistance during the exercise and walking sessions.
Group II: NMESExperimental Treatment2 Interventions
Device: Cionic Neural Sleeve NS-100. Participants will wear the device during the 12-week exercise and walking program and receive stimulation assistance during the exercise sessions.
Group III: ControlExperimental Treatment1 Intervention
Device: Cionic Neural Sleeve NS-100. Participants will wear the device during the 12-week exercise and walking program. There will be no stimulation.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NMES
2018
Completed Phase 4
~890
FES
2013
N/A
~200

Find a Location

Who is running the clinical trial?

Cionic, Inc.Lead Sponsor
3 Previous Clinical Trials
96 Total Patients Enrolled
~1 spots leftby Oct 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top